ATE11012T1 - Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt. - Google Patents

Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt.

Info

Publication number
ATE11012T1
ATE11012T1 AT81400446T AT81400446T ATE11012T1 AT E11012 T1 ATE11012 T1 AT E11012T1 AT 81400446 T AT81400446 T AT 81400446T AT 81400446 T AT81400446 T AT 81400446T AT E11012 T1 ATE11012 T1 AT E11012T1
Authority
AT
Austria
Prior art keywords
fluoro
indenylessigs
2methyl
benzylidene
ure
Prior art date
Application number
AT81400446T
Other languages
English (en)
Inventor
Tsung-Ying-Shen
Philippe Conquet
Jean-Claude Le Douarec
Original Assignee
Merck & Co. Inc.
Laboratoires Merck, Sharp & Dohme-Chibret
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc., Laboratoires Merck, Sharp & Dohme-Chibret filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE11012T1 publication Critical patent/ATE11012T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT81400446T 1980-03-21 1981-03-20 Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt. ATE11012T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13257480A 1980-03-21 1980-03-21
EP81400446A EP0036816B1 (de) 1980-03-21 1981-03-20 Ophthalmische Zusammensetzung, die 5-Fluor-2-methyl-1-(p-methylthio-benzyliden)-3-indenyl-essigsäure oder deren Salz enthält

Publications (1)

Publication Number Publication Date
ATE11012T1 true ATE11012T1 (de) 1985-01-15

Family

ID=22454656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81400446T ATE11012T1 (de) 1980-03-21 1981-03-20 Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt.

Country Status (9)

Country Link
EP (1) EP0036816B1 (de)
JP (1) JPS574920A (de)
AT (1) ATE11012T1 (de)
DE (1) DE3168004D1 (de)
DK (1) DK126681A (de)
ES (1) ES500574A0 (de)
GR (1) GR74444B (de)
IE (1) IE51036B1 (de)
PT (1) PT72696B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5848911B2 (ja) * 1978-03-20 1983-10-31 富士ゼロックス株式会社 磁気バブル表示素子

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325358A (en) * 1962-06-06 1967-06-13 Merck & Co Inc Method of treating inflammation
US3654349A (en) * 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
US3720774A (en) * 1971-07-20 1973-03-13 Merck & Co Inc Method of treating pain,fever or inflammation
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
US4087538A (en) * 1976-09-09 1978-05-02 Merck & Co., Inc. Ophthalmic suspensions

Also Published As

Publication number Publication date
ES8303317A1 (es) 1983-02-01
DK126681A (da) 1981-09-22
ES500574A0 (es) 1983-02-01
PT72696A (en) 1981-04-01
IE51036B1 (en) 1986-09-17
EP0036816A2 (de) 1981-09-30
DE3168004D1 (en) 1985-02-14
GR74444B (de) 1984-06-28
EP0036816B1 (de) 1985-01-02
PT72696B (en) 1982-11-16
JPS574920A (en) 1982-01-11
IE810628L (en) 1981-09-21
EP0036816A3 (en) 1981-11-04

Similar Documents

Publication Publication Date Title
GB1319390A (en) Process for sterilising contact lenses
AU623454B2 (en) Method of treating epithelial disorders
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ES513791A0 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
DE3176215D1 (en) Non-yellowing topical pharmaceutical composition
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
MX158408A (es) Un procedimiento para la preparacion de una composicion acuosa espesada de fluoruro de sodio
AU586808B2 (en) Purine derivatives
HU179483B (en) Herbicide and fungicide compositions containing phenoxy-propionic acid derivatives as active agents,and process for producing phenoxy-propionic acid derivatives
DE3260063D1 (en) Eye lotion composition based on chondroitin sulfate a
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
ATE11012T1 (de) Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt.
IT8022843A0 (it) Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1.chiusa par.quadrata-ottan-3-alchilcarbossilati , processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo.
AU538612B2 (en) Salt of furosemide or piretanide as acid component and penbutolol or (-)-3-(4-3-(3,4-dimethoxyphenylethylamino)-2- hydroxypropoxy)-phenyl)-crotonitrile as base component
IT8023161A0 (it) Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ATE73330T1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
AU537117B2 (en) Alpha-cyano-4-fluoro-3-phenoxybenzyl ester
IT7921809A0 (it) Metodo per la produzione di derivati dell'acido 6-beta-amidino-penicillanico.
ATE1338T1 (de) Therapeutische zusammensetzungen, die eine substituierte essigsaeure oder deren salz als aktive verbindung enthalten.
IT8222912A0 (it) Sali di etilendiammina, processo per la loro produzione e composizioni terapeutiche che li comprendono come principio attivo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee